Monitoring skeletal response to treatment: Which site to measure in the femur?

Journal of Clinical Densitometry

Volumn 3, Issue 2, 2000, Pages 149-155

  Blake, Glen M ^a   Preston, Nancy G ^a   Patel, Rajesh ^a   Herd, Ruth J M ^a   Fogelman, Ignac ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Dual X ray absorptiometry; Femur bone mineral density measurements; Longitudinal sensitivity

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ETIDRONIC ACID; PLACEBO;

ADULT; ARTICLE; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HIP; HUMAN; MAJOR CLINICAL STUDY; PATIENT MONITORING; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033940904     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1385/JCD:3:2:149     Document Type: Article

References (21)

1. 1. Melton LJ, Thamer M, Ray NF, et al. 1997 Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res 12:16-23.
2. 2. Ray NF, Chan JK, Thamer M, Melton LJ. 1997 Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12:24-35.
3. 3. Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA. 1992 Race and sex differences in mortality following fracture of the hip. Am J Public Health 82:1147-1150.
4. 4. Koval KJ, Skovron ML, Ahanonoff GB, Meadows SE, Zuckerman JD. 1995 Ambulatory ability after hip fracture: a prospective study in geriatric patients. Clin Orthop 310:150-159.
5. 5. Liberman UA, Weiss SR. Bröll J, et al. 1995 Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437-1443.
6. 6. Black DM, Cummings SR, Karpf DB, et al. 1996 Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535-1541.
7. 7. Delmas PD, Bjarnason NH, Mitlak BH, et al. 1997 Effects of raloxifine on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 337:1641-1647.
8. 8. Genant HK, Engelke K, Fuerst T, et al. 1996 Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res 11:707-730.
9. 9. Grampp S, Genant HK, Mathur A, et al. 1997 Comparisons of non-invasive bone mineral measurements in assessing age-related loss, fracture discrimination and diagnostic classification. J Bone Miner Res 12:697-711.
10. 10. Blake CM, Wahner HW, Fogelman I. 1999. The evaluation of osteoporosis: dual energy x-ray absorptiometry and ultrasound in clinical practice, 2nd ed. London: Martin Dunitz.
11. 11. Orwoll ES, Oviatt SK. 1991 Longitudinal precision of dual-energy X-ray absorptiometry in a multicenter study. J Bone Miner Res 6:191-197.
12. 12. Glüer C-C, Faulkner KG, Estilo MJ, Engelke K, Rosin J, Genant HK. 1993 Quality assurance for bone densitometry research studies: concept and impact. Osteoporos Int 3:227-235.
13. 13. Faulkner KG, McClung MR. 1995 Quality control of DXA instruments in multicenter trials. Osteoporos Int 5:218-227.
14. 14. Blake GM, Herd RJM, Fogelman I. 1996 A longitudinal study of supine lateral DXA of the lumbar spine: a comparison with posteroanterior spine, hip and total-body DXA. Osteoporos Int 6:462-470.
15. 15. Faulkner KG, McClung MR, Ravn P, et al. 1996 Monitoring skeletal response to therapy in early postmenopausal women: which bone to measure? J Bone Miner Res 11(Suppl. 1):S96.
16. 16. Eastell R. 1998 Treatment of postmenopausal osteoporosis. N Engl J Med 338:736-746.
17. 17. Hanson J. 1997 Letter to the editor: standardization of femur BMD. J Bone Miner Res 12:1316, 1317.
18. 18. Takada M, Grampp S, Ouyang X, Engelke K, Genant S. 1997 A new trabecular region of interest for femoral dual X-ray absorptiometry: short-term precision, age related bone loss and fracture discrimination compared with current femoral regions of interest. J Bone Miner Res 12:832-838.
19. 19. Herd RJM, Balena R, Blake GM, Ryan PJ, Fogelman I. 1997 The prevention of early postmenopausal bone loss by cyclical etidronate therapy: a 2-year double-blind placebo-controlled study. Am J Med 103:92-99.
20. 20. Blake GM, Preston NG, Patel R, Herd RJM, Fogelman I. 1999 An unexpected change in DXA calibration not detected by routine quality control checks. Osteoporos Int 9:115-120.
21. 21. Glüer C-C, Blake G, Lu Y, Blunt BA, Jergas M, Genant HK. 1995 Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int 5:262-270.